The Efficacy and Safety of CARTO 3D Mapping System Versus Conventional Method in AF and VT (CARTOAF&VT)

Korea University

Status and phase: Unknown; Phase 4

Conditions: Atrial Fibrillation

Treatments: Device: CARTO 3D; Device: Angiography

Study type: Interventional

Funder types: Other

Identifiers

NCT00959205

2009_KU_CARTO

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy and safety of electroanatomic imaging compared to conventional method in patients with VT.

Full description

To evaluate the efficacy and safety of electroanatomic imaging (CARTO) compared to conventional fluoroscopically guided activation mapping (Conventional) method in patients with Atrial Fibrillation and Substrate-dependent Ventricular Tachycardia To evaluate cost-effectiveness of CARTO 3D image system compared to conventional method in the same study subjects

Enrollment: 160 estimated patients

Sex: All

Ages: 20 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with AF or substrate-dependent VT

Exclusion criteria

• administering with anticoagulants

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

160 participants in 2 patient groups

Angiography

Active Comparator group

Description:

Conventional fluoroscopically guided activation mapping

Treatment:

Device: Angiography

CARTO 3D

Experimental group

Description:

CARTO (3D Electroanatomic imaging)

Treatment:

Device: CARTO 3D